Brevan Howard Capital Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,145
| Closed | -$57.8K | – | 1778 |
|
|
2025
Q1 | $57.8K | Buy |
+10,145
| New | +$57.8K | ﹤0.01% | 1040 |
|
|
2024
Q3 | – | Sell |
-13,814
| Closed | -$185K | – | 1150 |
|
|
2024
Q2 | $185K | Buy |
13,814
+5,418
| +65% | +$72.5K | ﹤0.01% | 856 |
|
|
2024
Q1 | $390K | Buy |
8,396
+206
| +3% | +$9.56K | ﹤0.01% | 502 |
|
|
2023
Q4 | $554K | Buy |
8,190
+5,317
| +185% | +$359K | 0.01% | 394 |
|
|
2023
Q3 | $208K | Sell |
2,873
-14,591
| -84% | -$1.06M | ﹤0.01% | 264 |
|
|
2023
Q2 | $1.3M | Hold |
17,464
| – | – | 0.03% | 58 |
|
|
2023
Q1 | $929K | Buy |
+17,464
| New | +$929K | 0.02% | 59 |
|